首页 › 基金 › Rosalind Advisors, Inc. › VOR
Rosalind Advisors, Inc. 对 VOR 的持仓历史
VOR BIOPHARMA INC · 医疗保健
Rosalind Advisors, Inc. 在 Q3 2026 的 13F 申报中披露持有 VOR(VOR BIOPHARMA INC)609,199 股,市值约 US$11.6M,约占其申报组合的 4.75%,在其申报持仓中市值排名第 6 位。 Rosalind Advisors, Inc. 最近 9 个申报季度中有 4 个季度披露了 VOR 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Rosalind Advisors, Inc. 对 VOR 的持仓演变
Rosalind Advisors, Inc. 于 Q3 2024 首次披露 VOR 持仓:76,685 股(约 US$54K)。 该持仓在 Q1 2026 达到峰值 700,000 股,市值约 US$12.5M。 在 4 次申报中,Rosalind Advisors, Inc. 0 次增持、2 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 609,199 股、市值约 US$11.6M,环比减持 -39,401 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 76.69K | $53.68K | 新进 |
| Q1 2026 | 700.00K | $12.49M | 新进 |
| Q2 2026 | 648.60K | $11.94M | 减持 |
| Q3 2026 | 609.20K | $11.62M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 VOR 与 13F 数据
VOR(VOR BIOPHARMA INC)属于医疗保健行业。我们追踪的基金中还有 70 只申报持有 VOR,申报仓位最大的包括:TCG Crossover Management, LLC (US$108.2M), FCPM III SERVICES B.V. (US$65.0M), Venrock Adviser, LLC (US$56.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 VOR 的基金
- TCG Crossover Management, LLC 5.67M 股 · $108.24M · Q3 2026
- FCPM III SERVICES B.V. 3.41M 股 · $64.97M · Q3 2026
- Venrock Adviser, LLC 3.04M 股 · $56.00M · Q2 2026
- Frazier Life Sciences Management, L.P. 2.54M 股 · $46.83M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 2.40M 股 · $44.22M · Q2 2026
- Caligan Partners LP 1.93M 股 · $35.44M · Q2 2026
- GREAT POINT PARTNERS LLC 1.70M 股 · $31.30M · Q2 2026
- Nantahala Capital Management, LLC 931.64K 股 · $17.78M · Q3 2026
- Paradigm Biocapital Advisors LP 889.58K 股 · $16.97M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 721.55K 股 · $13.77M · Q3 2026
- NEXTBio Capital Management LP 620.93K 股 · $11.85M · Q3 2026
- Vivo Capital, LLC 550.36K 股 · $10.50M · Q3 2026
更多关于 Rosalind Advisors, Inc.
常见问题
How long has Rosalind Advisors, Inc. held VOR?
Rosalind Advisors, Inc. has disclosed VOR holdings in 4 of the last 9 reported quarters, going back to Q3 2024.
What is Rosalind Advisors, Inc.'s current position in VOR?
As of Q3 2026, Rosalind Advisors, Inc. holds 609.20K shares of VOR (VOR BIOPHARMA INC), valued at $11.62M, representing 4.75% of its reported portfolio and ranking #6.
Has Rosalind Advisors, Inc. been buying or selling VOR?
In the latest 13F filing (Q3 2026), Rosalind Advisors, Inc. reduced its position in VOR. The position peaked in Q1 2026 at 700.00K shares.
Which other funds hold VOR?
Other major institutional holders of VOR include TCG Crossover Management, LLC, FCPM III SERVICES B.V., Venrock Adviser, LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.